6,094
Views
20
CrossRef citations to date
0
Altmetric
Review

First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI

&
Pages 1523-1538 | Received 03 May 2017, Accepted 05 Sep 2017, Published online: 03 Oct 2017